Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,463 | 42,271 | 47,886 | 45,789 | 27,750 |
| Marketable Securities | 23 | 17 | 19 | 2,016 | 4,961 |
| Receivables | 127 | 256 | 213 | 638 | 405 |
| TOTAL | $42,260 | $43,844 | $49,984 | $50,997 | $34,401 |
| Non-Current Assets | |||||
| PPE Net | 2,157 | 2,255 | 2,149 | 2,251 | 2,013 |
| Intangibles | 42,372 | 42,372 | 57,212 | 57,212 | 57,212 |
| Other Non-Current Assets | 2,850 | 2,328 | 2,408 | 2,758 | 2,968 |
| TOTAL | $47,379 | $46,955 | $61,769 | $62,221 | $62,193 |
| Total Assets | $89,639 | $90,799 | $111,753 | $113,218 | $96,594 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,550 | 4,451 | 4,978 | 5,437 | 4,477 |
| Other current liabilities | 3,766 | 5,257 | N/A | 7,388 | N/A |
| TOTAL | $9,382 | $10,756 | $13,089 | $13,977 | $13,864 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 6,931 | N/A | 8,250 |
| Other Non-Current Liabilities | 46,657 | 19,759 | 7,078 | 7,433 | 1,500 |
| TOTAL | $59,461 | $32,931 | $21,009 | $22,229 | $17,936 |
| Total Liabilities | $68,843 | $43,687 | $34,098 | $36,206 | $31,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 230,328 | 228,356 | 228,356 | 228,356 | 188,837 |
| Common Shares | 494,175 | 490,551 | 489,313 | 484,722 | 469,268 |
| Retained earnings | -467,849 | -438,068 | -407,604 | -403,465 | -400,192 |
| Other shareholders' equity | -5,530 | -5,371 | -4,054 | -4,245 | -4,282 |
| TOTAL | $20,796 | $47,112 | $77,655 | $77,012 | $64,794 |
| Total Liabilities And Equity | $89,639 | $90,799 | $111,753 | $113,218 | $96,594 |